References
- 1BaF, MartinWR Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord 2015;21:87–94. doi: 10.1016/j.parkreldis.2014.11.00725487733
- 2ScherflerC, SchwarzJ, AntoniniA, GrossetD, ValldeoriolaF, MarekK, et al. Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord 2007;22:1229–1238. doi: 10.1002/mds.2150517486648
- 3SeibylJP, MarekKL, QuinlanD, SheffK, ZoghbiS, Zea-PonceY, et al. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Ann Neurol 1995;38:589–598. doi: 10.1002/ana.4103804077574455
- 4AsenbaumS, BruckeT, PirkerW, PodrekaI, AngelbergerP, WengerS, et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson’s disease. J Nucl Med 1997;38:1–6.8998140
- 5HongJY, OhJS, LeeI, SunwooMK, HamJH, LeeJE, et al. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease. Neurology 2014;82:1597–1604. doi: 10.1212/WNL.000000000000038524719485
- 6JeonBS, JeongJM, ParkSS, KimJM, ChangYS, SongHC, et al. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998;43:792–800. doi: 10.1002/ana.4104306149629849
- 7O’SullivanJD, CostaDC, GacinovicS, LeesAJ SPECT imaging of the dopamine transporter in juvenile-onset dystonia. Neurology 2001;56:266–267. doi: 10.1212/wnl.56.2.26611160970
- 8LorberboymM, TrevesTA, MelamedE, LamplY, HellmannM, DjaldettiR [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson’s disease. Mov Disord 2006;21:510–514. doi: 10.1002/mds.2074816250023
- 9SadasivanS, FriedmanJH Experience with DaTscan at a tertiary referral center. Parkinsonism Relat Disord 2015;21:42–45. doi: 10.1016/j.parkreldis.2014.10.02225465746